Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,075 USD | +1,42% | +10,06% | +35,56% |
Omzet 2024 * | 87,81 mln. 82,13 mln. | Omzet 2025 * | 62,82 mln. 58,75 mln. | Marktkapitalisatie | 275 mln. 257 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -88 mln. -82,3 mln. | Nettowinst (verlies) 2025 * | -130 mln. -122 mln. | EV/omzet 2024 * | 3,13 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 4,37 x |
K/w-verhouding 2024 * |
-2,93
x | K/w-verhouding 2025 * |
-2,3
x | Werknemers | 449 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 15,06% |
Recentste transcriptie over Adaptimmune Therapeutics plc
1 dag | +1,42% | ||
1 week | +10,06% | ||
Lopende maand | -31,96% | ||
1 maand | -29,28% | ||
3 maanden | +47,26% | ||
6 maanden | +91,96% | ||
Lopend jaar | +35,56% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Founder | 57 | 01-01-08 | |
Adrian Rawcliffe
CEO | Chief Executive Officer | 52 | 01-03-15 |
Gavin Wood
DFI | Director of Finance/CFO | 54 | 01-04-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Kristen Hege
BRD | Director/Board Member | 60 | 01/11 |
Andrew Allen
BRD | Director/Board Member | 57 | 01-06-23 |
David Mott
CHM | Chairman | 58 | 01-09-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.01% | 0 M€ | 0,00% | - | |
0.01% | 0 M€ | 0,00% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 1,075 | +1,42% | 1 162 546 |
25-04-24 | 1,06 | -1,85% | 565 527 |
24-04-24 | 1,08 | -5,26% | 786 554 |
23-04-24 | 1,14 | +12,87% | 1 133 640 |
22-04-24 | 1,01 | +3,41% | 694 255 |
uitgestelde koers Nasdaq, 26 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+35,56% | 275 mln. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,74 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |